Supplementary Figure S13 from Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
Le résumé fourni par la source
Switch-off/on EGFR activity in NCI-H1385 cells. a. Experimental scheme: Low EGFR activitywild-type NCI-H1385 cells were knocked-out (KO) for endogenous EGFR by a CRISPR/Cas vector, then stably transfected with an expression vector encoding L858R EGFR. b. Immunoblot of EGFR in wild-type (wt) NCI-H1385 cells and in clones subjected to two (#1, #2) EGFR-CRISPR/Cas vectors. Tubulin is included as control of equal protein loading. The image is representative of one of three experiments. c. L858R EGFR mRNA levels in wt NCI-H1385 cells and in cells stably transfected with the L858R EGFR-expression vector, measured by RT-PCR (technical triplicates). Data are means + SD (n=3, biological replicates). ***p<0.001: L858R cells versus wt cells (ANOVA). d. Immunoblot of EGFR in wt and L858R NCI-H1385 cells. Tubulin is included as control of equal protein loading. The image is representative of one of three experiments. e. EGFR kinase activity, measured in wt and L858R NCI-H1385 cells by a chemiluminescence-based assay in technical duplicates. Data are means+SD (n=3, biological replicates). ***p<0.001: L858R cells versus wt cells (ANOVA).
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Supplementary Figure S13 from Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
- Date Crossref
- 25/11/2025
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.